Skip to content

2-methyl-4-[(1-methyl-3-phenyl-4,5,7,8-tetrahydropyrazolo[4,5-d]azepin-6-yl)methyl]-1H-pyrimidin-6-one

C20H23N5O — CID 154571589

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPAC2-methyl-4-[(1-methyl-3-phenyl-4,5,7,8-tetrahydropyrazolo[4,5-d]azepin-6-yl)methyl]-1H-pyrimidin-6-one
SMILESCc1nc(CN2CCc3c(-c4ccccc4)nn(C)c3CC2)cc(=O)[nH]1
InChIInChI=1S/C20H23N5O/c1-14-21-16(12-19(26)22-14)13-25-10-8-17-18(9-11-25)24(2)23-20(17)15-6-4-3-5-7-15/h3-7,12H,8-11,13H2,1-2H3,(H,21,22,26)
InChIKeyVAVMCWSLYFMTCM-UHFFFAOYSA-N
MW349.44 g/mol
LogP2.08
Rot. Bonds3

About 2-methyl-4-[(1-methyl-3-phenyl-4,5,7,8-tetrahydropyrazolo[4,5-d]azepin-6-yl)methyl]-1H-pyrimidin-6-one

2-methyl-4-[(1-methyl-3-phenyl-4,5,7,8-tetrahydropyrazolo[4,5-d]azepin-6-yl)methyl]-1H-pyrimidin-6-one (PubChem CID 154571589) has the molecular formula C20H23N5O and a molecular weight of 349.44 g/mol. Its IUPAC name is 2-methyl-4-[(1-methyl-3-phenyl-4,5,7,8-tetrahydropyrazolo[4,5-d]azepin-6-yl)methyl]-1H-pyrimidin-6-one.

Molecular Properties

Compound Name2-methyl-4-[(1-methyl-3-phenyl-4,5,7,8-tetrahydropyrazolo[4,5-d]azepin-6-yl)methyl]-1H-pyrimidin-6-one
PubChem CID154571589
Molecular FormulaC20H23N5O
Molecular Weight349.44 g/mol
Exact Mass349.19
IUPAC Name2-methyl-4-[(1-methyl-3-phenyl-4,5,7,8-tetrahydropyrazolo[4,5-d]azepin-6-yl)methyl]-1H-pyrimidin-6-one
SMILESCc1nc(CN2CCc3c(-c4ccccc4)nn(C)c3CC2)cc(=O)[nH]1
InChIInChI=1S/C20H23N5O/c1-14-21-16(12-19(26)22-14)13-25-10-8-17-18(9-11-25)24(2)23-20(17)15-6-4-3-5-7-15/h3-7,12H,8-11,13H2,1-2H3,(H,21,22,26)
InChIKeyVAVMCWSLYFMTCM-UHFFFAOYSA-N
XLogP2.08
TPSA66.81 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds3
Heavy Atoms26
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500349.44
LogP ≤ 52.08
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Analyze 2-methyl-4-[(1-methyl-3-phenyl-4,5,7,8-tetrahydropyrazolo[4,5-d]azepin-6-yl)methyl]-1H-pyrimidin-6-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-methyl-4-[(1-methyl-3-phenyl-4,5,7,8-tetrahydropyrazolo[4,5-d]azepin-6-yl)methyl]-1H-pyrimidin-6-one?
The IUPAC name of 2-methyl-4-[(1-methyl-3-phenyl-4,5,7,8-tetrahydropyrazolo[4,5-d]azepin-6-yl)methyl]-1H-pyrimidin-6-one (CID 154571589) is 2-methyl-4-[(1-methyl-3-phenyl-4,5,7,8-tetrahydropyrazolo[4,5-d]azepin-6-yl)methyl]-1H-pyrimidin-6-one.
What is the SMILES notation for 2-methyl-4-[(1-methyl-3-phenyl-4,5,7,8-tetrahydropyrazolo[4,5-d]azepin-6-yl)methyl]-1H-pyrimidin-6-one?
The canonical SMILES for 2-methyl-4-[(1-methyl-3-phenyl-4,5,7,8-tetrahydropyrazolo[4,5-d]azepin-6-yl)methyl]-1H-pyrimidin-6-one is Cc1nc(CN2CCc3c(-c4ccccc4)nn(C)c3CC2)cc(=O)[nH]1.
What is the InChIKey of 2-methyl-4-[(1-methyl-3-phenyl-4,5,7,8-tetrahydropyrazolo[4,5-d]azepin-6-yl)methyl]-1H-pyrimidin-6-one?
The InChIKey is VAVMCWSLYFMTCM-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H23N5O/c1-14-21-16(12-19(26)22-14)13-25-10-8-17-18(9-11-25)24(2)23-20(17)15-6-4-3-5-7-15/h3-7,12H,8-11,13H2,1-2H3,(H,21,22,26).
What are the key properties of 2-methyl-4-[(1-methyl-3-phenyl-4,5,7,8-tetrahydropyrazolo[4,5-d]azepin-6-yl)methyl]-1H-pyrimidin-6-one?
2-methyl-4-[(1-methyl-3-phenyl-4,5,7,8-tetrahydropyrazolo[4,5-d]azepin-6-yl)methyl]-1H-pyrimidin-6-one has a molecular weight of 349.44 g/mol, XLogP of 2.08, 3 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 2-methyl-4-[(1-methyl-3-phenyl-4,5,7,8-tetrahydropyrazolo[4,5-d]azepin-6-yl)methyl]-1H-pyrimidin-6-one is sourced from PubChem (CID 154571589), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.